Azidothymidine or zidovudine
- Level
- Commodity
- Parent
- 51343100
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51343116This classification denotes a reverse transcriptase inhibitor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4B9XT59T7S. European Medicines Agency schedules Zidovudine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00153MIG. Zidovudine generally arises in the molecular formula C10H13N5O4. The term ZIDOVUDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 1, no. 4, 1987, list 27.) ZIDOVUDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Azidothymidine or zidovudine bears US NLM identifiers UMLS ID C0043474 and NCI Concept Code C947. SMILES: CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-].
Same parent
Under 51343100 · 17Activities that produce or sell this
KBLI · 8Inherited from family 51340000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.